Home - Products - Others - Other Targets - 6-(4-methylpiperazin-1-yl)-4-o-tolylnicotinamide

6-(4-methylpiperazin-1-yl)-4-o-tolylnicotinamide

CAS No. 342417-01-0

6-(4-methylpiperazin-1-yl)-4-o-tolylnicotinamide( —— )

Catalog No. M28871 CAS No. 342417-01-0

6-(4-methylpiperazin-1-yl)-4-o-tolylnicotinamide can be used in the synthesis of befetupitant and netupitant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG 642 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-(4-methylpiperazin-1-yl)-4-o-tolylnicotinamide
  • Note
    Research use only, not for human use.
  • Brief Description
    6-(4-methylpiperazin-1-yl)-4-o-tolylnicotinamide can be used in the synthesis of befetupitant and netupitant.
  • Description
    6-(4-methylpiperazin-1-yl)-4-o-tolylnicotinamide can be used in the synthesis of befetupitant and netupitant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CCR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    342417-01-0
  • Formula Weight
    310.401
  • Molecular Formula
    C18H22N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1CCN(CC1)c1cc(c(cn1)C(N)=O)-c1ccccc1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Maria Grazia Martina, et al. Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases. Eur J Med Chem. 2022 Aug 29;243:114703.
molnova catalog
related products
  • 72'-Dihydroxy-3'4'-d...

    72'-Dihydroxy-3'4'-dimethoxyisoflavan is a natural product.

  • Lesinurad

    Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout.

  • Ginsenoside F4

    Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.